CN103877519A - Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases - Google Patents
Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN103877519A CN103877519A CN201410143818.9A CN201410143818A CN103877519A CN 103877519 A CN103877519 A CN 103877519A CN 201410143818 A CN201410143818 A CN 201410143818A CN 103877519 A CN103877519 A CN 103877519A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases. The composition contains the following materials: keiskei, rhizoma acori graminei, rhizoma curcumae longae, curcuma aromatica, pseudo-ginseng, prepared nutgrass galingale rhizome, salvia miltiorrhiza, lignum dalbergiae odoriferae, rhizoma corydalis, leeches, ligusticum wallichii, root of kudzu vine, angelica, sargentgloryvine stem, fried trogopterus dung, giant knot weed, raw pollen typhae, safflower, prepared pinellia ternate, fructus schisandrae, common andrographis herb, astragalus membranaceus, Chinese honey locust and mint. When being adopted less, the traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases disclosed by the invention functions as promoting circulation of qi and regulating blood, and has preventive and health caring functions on early stroke form and spirit feeling symptoms as sourness, swelling, stuffiness, pain, palpitation, terrifying and chest obstruction preventive disease engineering. When being frequently used, the composition can promote flow of qi and blood circulation, and is effective for medium stroke form and spirit feeling symptoms as numbness of limbs, weakness and fatigue. The composition has certain treatment and rehabilitation effects on stabbing pain of heart and brain, oppressive pain, angina, numbness pain, swelling pain and an eight-afraid symptom. The composition, being repeatedly used, functions as promoting circulation of qi and dissolving stasis, and has functions of removing depression and stasis on stroke form and spirit feeling symptoms as limb hemiplegia, stasis, infarct and blood exhaustion, brain injury, paraplegia, aphasia and imperception.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease.
Background technology
Coronary heart disease is because coronary atherosclerosis causes.Impel the many factors of coronary atherosclerosis. mainly contain hypertension, diabetes, smoking, overweight, mental work and the work etc. of sitting quietly, while is along with the continuous growth at age, blood vessel wall, especially arteriole, as the theca interna degeneration such as coronary artery, renal artery, cerebral arteries, calcinosis. cause blood vessel wall sclerosis. calcinosis simultaneously.Intravascular space is narrowed, slow blood flow, the visible component in blood, particularly fibrin and platelet aggregation, cause thrombosis, causes blood vessel embolism, therefore for the prevention of coronary heart disease, cerebral thrombosis, remove in the ban risk factor, as non-smoking, strengthen physical exertion, the people that takes the photograph who reduces cholesterol measures, periodic review blood pressure, to control in time as raise, treatment hyperlipemia, keeps suitable body weight, prevents obesity.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, the material that it comprises following weight proportioning: Herba Convallariae (Latin formal name used at school Convallaria majalis L) 10-15 part, Rhizoma Acori Graminei 15-20 part, Rhizoma Curcumae Longae 25-30 part, Radix Curcumae 15-20 part, Radix Notoginseng 10-15 part, Rhizoma Cyperi (processed) 20-25 part, Radix Salviae Miltiorrhizae 35-40 part, Lignum Dalbergiae Odoriferae 10-15 part, Rhizoma Corydalis 25-30 part, Hirudo 5-10 part, Rhizoma Chuanxiong 20-25 part, Radix Puerariae 20-25 part, Radix Angelicae Sinensis 15-20 part, Caulis Sargentodoxae 30-40 part, Oletum Trogopterori (parched) 10-15 part, Rhizoma Polygoni Cuspidati 20-25 part, Pollen Tyjphae 10-15 part, Flos Carthami 10-15 part, Rhizoma Pinelliae Preparata 20-25 part, Radix Schisandrae Bicoloris 30-40 part, Herba Andrographis 15-20 part, Radix Astragali 50-60 part, Fructus Gleditsia 15-20 part and Herba Menthae 10-15 part.
Preferably, the material that the Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of the present invention comprises following weight proportioning: 10 parts of 10 parts of Herba Convallariaes, 15 parts of Rhizoma Acori Graminei, 25 parts, Rhizoma Curcumae Longae, 15 parts of Radix Curcumaes, 10 parts of Radix Notoginseng, 20 parts of Rhizoma Cyperi (processed), 35 parts of Radix Salviae Miltiorrhizaes, 10 parts of Lignum Dalbergiae Odoriferaes, 25 parts of Rhizoma Corydalis, 5 parts of Hirudos, 20 parts of Rhizoma Chuanxiongs, 20 parts of Radix Puerariaes, 15 parts of Radix Angelicae Sinensis, 30 parts of Caulis Sargentodoxae, 10 parts of Oletum Trogopterori (parched)s, 20 parts of Rhizoma Polygoni Cuspidati, 10 parts of Pollen Tyjphae, 10 parts, Flos Carthami, 20 parts of Rhizoma Pinelliae Preparata, 30 parts of Radix Schisandrae Bicoloriss, 15 parts of Herba Andrographis, 50 parts of the Radixs Astragali, 15 parts, Fructus Gleditsia and Herba Menthaes.
More preferably, the Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of the present invention also comprises the material of following weight proportioning: 50 parts of 30 parts of Herba Stylophori Lasiocapi, 50 parts of Herba Lysimachiae Insigniss, 60 parts of Oreas martiana (Hopp. Et Hornsch.) Brid., 30 parts of Herba Cirrohopetali Andersoniis, 80 parts of Arillus Longans, 10 parts of Lignum Sappans, 30 parts of Flos Eriocaulis, 50 parts of Semen Linis, 60 parts of the Radix Pulsatillaes, 60 parts of Rhizoma Imperataes, 50 parts of Retinervus Luffae Fructuss, 20 parts of Herba Inulae, 30 parts of Radix Et Caulis Acanthopanacis Senticosis, 20 parts of Cortex Fraxinis, 60 parts of the Fructus Kochiae, 50 parts of Herba Corydalis Bungeanaes, 15 parts of Ilex purpurea Hassk.[I.chinensis Sims, 20 parts of Herba Sarcandraes and Radix Cynanchi Atratis.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, powder or capsule.
In the present invention:
Herba Stylophori Lasiocapi
Ji Yuan: be whole herb with root or the root of Papaveraceae Stylophorum plant human blood grass.
Former plant: human blood grass Stylophorum lasiocarpum (Oliv.) Fedde
Herba Lysimachiae Insignis
Ji Yuan: be herb or the root of Primulaceae Lysimachia plant SANYE Rhizoma et radix valerianae
Former plant: SANYE Rhizoma et radix valerianae Lysimachia insignis Hemsl.
Oreas martiana (Hopp. Et Hornsch.) Brid.
Ji Yuan: be the plant of hair Rhodobryum plant mountain, Dicranaceae mountain hair moss.
Former plant: mountain hair moss Oreas martiana (Hopp.et Homsch.) Brid.[Weisia martiana Hopp.et Hornasch.]
Herba Cirrohopetali Andersonii
Ji Yuan: be the herb of the orchid family volume lobe epidendrum comb cap volume lobe orchid.
Former plant: the blue Cirrhopetalnm andersonii of comb cap volume lobe Hook.f.[C.henryi Rolfe]
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, powder or capsule.
The Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of the present invention has the effect of supplementing QI and nourishing YIN, clearing heat and moistening dryness, promoting the production of body fluid to quench thirst.
Detailed description of the invention
Embodiment 1:
Take 10 grams of 10 grams of Herba Convallariaes, 15 grams of Rhizoma Acori Graminei, 25 grams, Rhizoma Curcumae Longae, 15 grams of Radix Curcumaes, 10 grams of Radix Notoginseng, 20 grams of Rhizoma Cyperi (processed), 35 grams of Radix Salviae Miltiorrhizaes, 10 grams of Lignum Dalbergiae Odoriferaes, 25 grams of Rhizoma Corydalis, 5 grams of Hirudos, 20 grams of Rhizoma Chuanxiongs, 20 grams of Radix Puerariaes, 15 grams of Radix Angelicae Sinensis, 30 grams of Caulis Sargentodoxae, 10 grams of Oletum Trogopterori (parched)s, 20 grams of Rhizoma Polygoni Cuspidati, 10 grams of Pollen Tyjphae, 10 grams, Flos Carthami, 20 grams of Rhizoma Pinelliae Preparata, 30 grams of Radix Schisandrae Bicoloriss, 15 grams of Herba Andrographis, 50 grams of the Radixs Astragali, 15 grams, Fructus Gleditsia and Herba Menthaes, pulverize, cross 100 mesh sieves, mix homogeneously, then divide and install in 100 capsule shells, obtain capsule of the present invention.
Embodiment 2:
Take 10 grams of Herba Convallariaes, 15 grams of Rhizoma Acori Graminei, 25 grams, Rhizoma Curcumae Longae, 15 grams of Radix Curcumaes, 10 grams of Radix Notoginseng, 20 grams of Rhizoma Cyperi (processed), 35 grams of Radix Salviae Miltiorrhizaes, 10 grams of Lignum Dalbergiae Odoriferaes, 25 grams of Rhizoma Corydalis, 5 grams of Hirudos, 20 grams of Rhizoma Chuanxiongs, 20 grams of Radix Puerariaes, 15 grams of Radix Angelicae Sinensis, 30 grams of Caulis Sargentodoxae, 10 grams of Oletum Trogopterori (parched)s, 20 grams of Rhizoma Polygoni Cuspidati, 10 grams of Pollen Tyjphae, 10 grams, Flos Carthami, 20 grams of Rhizoma Pinelliae Preparata, 30 grams of Radix Schisandrae Bicoloriss, 15 grams of Herba Andrographis, 50 grams of the Radixs Astragali, 15 grams, Fructus Gleditsia, 10 grams of Herba Menthaes, 30 grams of Herba Stylophori Lasiocapi, 50 grams of Herba Lysimachiae Insigniss, 60 grams of Oreas martiana (Hopp. Et Hornsch.) Brid., 30 grams of Herba Cirrohopetali Andersoniis, 80 grams of Arillus Longans, 10 grams of Lignum Sappans, 30 grams of Flos Eriocaulis, 50 grams of Semen Linis, 60 grams of the Radix Pulsatillaes, 60 grams of Rhizoma Imperataes, 50 grams of Retinervus Luffae Fructuss, 20 grams of Herba Inulae, 30 grams of Radix Et Caulis Acanthopanacis Senticosis, 20 grams of Cortex Fraxinis, 60 grams of the Fructus Kochiae, 50 grams of Herba Corydalis Bungeanaes, 15 grams of Ilex purpurea Hassk.[I.chinensis Sims, 50 grams of 20 grams of Herba Sarcandraes and Radix Cynanchi Atratis, pulverize, cross 100 mesh sieves, mix homogeneously, then divide and install in 100 capsule shells, obtain capsule of the present invention.
Experimental example
Physical data
Patients with coronary heart disease 56 examples, male 32 examples, female's 24 examples; The oldest 82 years old, minimum 45 years old, average 66 years old; The course of disease is the longest 21 years, the shortest 3 years; Wherein there are typical angina pectoris attacks 6 examples, unstable angina pectoris 12 examples of showing effect; Coronary heart disease occasional premature beat 7 examples that occur together, coronary heart disease merges and continues atrial fibrillation 3 examples, has old myocardial infarction 5 examples, 8 examples after percutaneous transluminal coronary stent implantation; After activity, having at ordinary times slight sensation of oppression over the chest with shortness of breath 12 examples, is salty asthma 3 examples of feeling suffocated after gentle activity; 56 routine Electrocardioscopy are chronic coronary artery blood supply insufficiency.Patient is divided into 2 groups, every group of each 28 examples, two groups sex, age, the course of disease, etc. relatively there was no significant difference (P>0.05) of aspect, there is comparability.
First group of capsule prepared by the oral embodiment 1 of patient, every day 1 time, each oral 2, treats 1 year continuously.Second group of capsule prepared by the oral embodiment 2 of patient, every day 1 time, each oral 2, treats 1 year continuously.
Efficacy assessment standard
" clinical disease diagnosis is according to curing improvement standard " that efficacy assessment standard is write according to The General Logistics Department of PLA cures: subjective symptoms disappears completely, and it is normal that every inspection all belongs to; Effective: subjective symptoms disappears substantially, every inspection approaches normal; Effective: subjective symptoms obviously alleviates, every inspection is all improved; Invalid: subjective symptoms, clinical examination are all without any change.
Result
In first group, cure 9 examples, effective 8 examples, effective 5 examples, invalid 6, total effective rate is 78.6%.In second group, cure 15 examples, effective 5 examples, effective 6 examples, invalid 2, total effective rate is 92.8%.
In treatment, observe, do not occur serious adverse reaction, in treatment, monthly the blood to two groups of patients, urine, stool routine and hepatic and renal function check, are showed no abnormal.
Claims (4)
1. treat the Chinese medicine composition of cardiovascular and cerebrovascular disease for one kind, it is characterized in that the material that it comprises following weight proportioning: Herba Convallariae 10-15 part, Rhizoma Acori Graminei 15-20 part, Rhizoma Curcumae Longae 25-30 part, Radix Curcumae 15-20 part, Radix Notoginseng 10-15 part, Rhizoma Cyperi (processed) 20-25 part, Radix Salviae Miltiorrhizae 35-40 part, Lignum Dalbergiae Odoriferae 10-15 part, Rhizoma Corydalis 25-30 part, Hirudo 5-10 part, Rhizoma Chuanxiong 20-25 part, Radix Puerariae 20-25 part, Radix Angelicae Sinensis 15-20 part, Caulis Sargentodoxae 30-40 part, Oletum Trogopterori (parched) 10-15 part, Rhizoma Polygoni Cuspidati 20-25 part, Pollen Tyjphae 10-15 part, Flos Carthami 10-15 part, Rhizoma Pinelliae Preparata 20-25 part, Radix Schisandrae Bicoloris 30-40 part, Herba Andrographis 15-20 part, Radix Astragali 50-60 part, Fructus Gleditsia 15-20 part and Herba Menthae 10-15 part.
2. the Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1, is characterized in that the material that it comprises following weight proportioning: 10 parts of 10 parts of Herba Convallariaes, 15 parts of Rhizoma Acori Graminei, 25 parts, Rhizoma Curcumae Longae, 15 parts of Radix Curcumaes, 10 parts of Radix Notoginseng, 20 parts of Rhizoma Cyperi (processed), 35 parts of Radix Salviae Miltiorrhizaes, 10 parts of Lignum Dalbergiae Odoriferaes, 25 parts of Rhizoma Corydalis, 5 parts of Hirudos, 20 parts of Rhizoma Chuanxiongs, 20 parts of Radix Puerariaes, 15 parts of Radix Angelicae Sinensis, 30 parts of Caulis Sargentodoxae, 10 parts of Oletum Trogopterori (parched)s, 20 parts of Rhizoma Polygoni Cuspidati, 10 parts of Pollen Tyjphae, 10 parts, Flos Carthami, 20 parts of Rhizoma Pinelliae Preparata, 30 parts of Radix Schisandrae Bicoloriss, 15 parts of Herba Andrographis, 50 parts of the Radixs Astragali, 15 parts, Fructus Gleditsia and Herba Menthaes.
3. the Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1 and 2, is characterized in that also comprising the material of following weight proportioning: 50 parts of 30 parts of Herba Stylophori Lasiocapi, 50 parts of Herba Lysimachiae Insigniss, 60 parts of Oreas martiana (Hopp. Et Hornsch.) Brid., 30 parts of Herba Cirrohopetali Andersoniis, 80 parts of Arillus Longans, 10 parts of Lignum Sappans, 30 parts of Flos Eriocaulis, 50 parts of Semen Linis, 60 parts of the Radix Pulsatillaes, 60 parts of Rhizoma Imperataes, 50 parts of Retinervus Luffae Fructuss, 20 parts of Herba Inulae, 30 parts of Radix Et Caulis Acanthopanacis Senticosis, 20 parts of Cortex Fraxinis, 60 parts of the Fructus Kochiae, 50 parts of Herba Corydalis Bungeanaes, 15 parts of Ilex purpurea Hassk.[I.chinensis Sims, 20 parts of Herba Sarcandraes and Radix Cynanchi Atratis.
4. according to the Chinese medicine composition of the treatment cardiovascular and cerebrovascular disease described in any one in claims 1 to 3, it is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, powder or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410143818.9A CN103877519A (en) | 2014-04-11 | 2014-04-11 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410143818.9A CN103877519A (en) | 2014-04-11 | 2014-04-11 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103877519A true CN103877519A (en) | 2014-06-25 |
Family
ID=50946855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410143818.9A Pending CN103877519A (en) | 2014-04-11 | 2014-04-11 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103877519A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106334055A (en) * | 2015-07-07 | 2017-01-18 | 上海市第十人民医院 | Chinese medicinal composition for treatment of cerebral ischemia reperfusion injury and application thereof |
| CN108261527A (en) * | 2017-01-04 | 2018-07-10 | 刘宝昌 | A kind of Chinese medicine composition for treating cardiovascular and cerebrovascular disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1108542A (en) * | 1993-09-08 | 1995-09-20 | 王印豪 | Double medicinal-core health-care bag for abdomen |
| CN101698090A (en) * | 2009-11-19 | 2010-04-28 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof |
-
2014
- 2014-04-11 CN CN201410143818.9A patent/CN103877519A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1108542A (en) * | 1993-09-08 | 1995-09-20 | 王印豪 | Double medicinal-core health-care bag for abdomen |
| CN101698090A (en) * | 2009-11-19 | 2010-04-28 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106334055A (en) * | 2015-07-07 | 2017-01-18 | 上海市第十人民医院 | Chinese medicinal composition for treatment of cerebral ischemia reperfusion injury and application thereof |
| CN108261527A (en) * | 2017-01-04 | 2018-07-10 | 刘宝昌 | A kind of Chinese medicine composition for treating cardiovascular and cerebrovascular disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1302805C (en) | Ready prepared Chinese medicine for preventing and treating brain apoplexia | |
| CN100441212C (en) | Chinese medicine for treating cardiac failure | |
| CN103784820A (en) | Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease | |
| CN100473411C (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN105169076A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN104721425A (en) | Traditional Chinese medicine foot bath powder for improving sleep, and preparation and use methods thereof | |
| CN104258350A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome and preparation method of traditional Chinese medicine preparation | |
| CN101897879A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN103877519A (en) | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
| CN104998202A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN101391081A (en) | Medicine composition for treating qi and blood derangement of essential hypertension and preparation method thereof | |
| CN103330825A (en) | Traditional Chinese medicinal preparation for treating heart disease | |
| CN106138772A (en) | Gastrodia tuber and fleece-flower root combined pharmaceutical composition and preparation technology thereof | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN105126034A (en) | Pharmaceutical preparation for treating coronary heart disease | |
| CN105381289A (en) | Pharmaceutical composition for treating abnormal menstruation | |
| CN104474524A (en) | Traditional Chinese medicine composition for treating viral myocarditis | |
| CN104274815A (en) | Traditional Chinese medicine composition for treating dysmenorrhea due to deficiency of vital energy and blood | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN105106786B (en) | The external medicine composition and its preparation and preparation method of a kind of Tongluo Shujin | |
| CN108014313A (en) | A kind of hand warmer pocket for being used to treat chill nasal obstruction | |
| CN101401881B (en) | Chinese medicinal composition for treating poison produced by venomous insects | |
| CN105362610A (en) | Traditional Chinese medicine composition for treating coronary artery diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140625 |